News

Deal Announcements

Genetix Pulls In $35 Million Second Venture Capital

Monday, March 15, 2010 5:31:00 AM PDT | VentureDeal Staff
Cambridge, Massachusetts  --  Pharmaceutical technology company Genetix Pharmaceuticals has raised $35 million in its second round of institutional venture capital investment.

Genetix is developing hemoglobin gene therapy technologies to treat life-threatening diseases.

Investors in the round included Third Rock Ventures, Genzyme Ventures, TVM Capital, Forbion Capital Partners and Easton Capital.  The company said it would use the funding proceeds to advance its current clinical programs.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1